Dihexa (N-hexanoic-Tyr-Ile-(6) amino hexanoic amide) is a small hexapeptide derived from angiotensin IV, engineered by researchers at Washington State University for dramatically enhanced metabolic stability and blood-brain barrier penetration. It acts as a potent activator of the hepatocyte growth factor (HGF) / c-Met system, a pathway central to synapse formation, dendritic spine growth, and neural repair.
In preclinical models, Dihexa has been reported to be roughly seven orders of magnitude more potent than brain-derived neurotrophic factor (BDNF) at facilitating new synapse formation, and it has restored cognitive function in aged and cognitively impaired rodents. This has made it one of the most closely watched compounds in nootropic and neurodegeneration research.
BioPeptideX supplies Dihexa as a 5 mg lyophilized powder, ≥99% HPLC verified, sealed under inert atmosphere and shipped with a Certificate of Analysis. Every vial is lot-traceable — for laboratory research use only.